The shares of a chemical manufacturing stock hit a 20 % upper circuit after the company’s financial results show robust Net profit growth of 241 percent year over year, and revenues grow by 12%
The shares of Transpek Industry Ltd, with a market capitalization of Rs. 698.84 crores on Thursday. Its shares are trading at a CMP of Rs 1501.35, against the previous closing price of Rs 1,251.15. The stock has hit a 20 percent upper circuit
What Happened
Transpek Industry Ltd, a chemical manufacturing and export company, has announced its results for the Financial year ‘25. Its Revenue grew by 12 percent YoY from Rs. 148 Crores in Q4FY24 to Rs. 165 Crores in Q4FY25, and it has decreased by close to 3 percent QoQ from Rs. 170 Crores in Q3FY25 to Rs. 165 Crores in Q4FY25.
Its Net Profit grew by 241 percent YoY from Rs. 5.64 Crores in Q4FY24 to Rs. 19.2 Crores in Q4FY25. The Net profits have grown by 81 percent QoQ from Rs. 10.6 Crores in Q3FY25 to Rs. 19.2 Crores in Q4FY25.
The company’s Earnings Before Interest, Depreciation, and Taxes (EBIDT) has also grown by 72 percent YOY from Rs 18.8 crores in Q4FY24 to Rs 32.2 crores in Q4FY25. Its EPS has also grown by 241 percent YOY from Rs. 10.10 in Q4FY24 to Rs. 34.46 in Q4FY25.
About the company
Transpek Industry Limited is a prominent global supplier of chlorinated products, serving a wide range of industries including Pharmaceuticals, Agrochemicals, Dyes, and Pigments. With extensive expertise in chlorinated chemistry, the company offers vast opportunities in the supply of intermediates and specialty chemicals tailored for various applications. Currently,
Transpek manufactures and exports a broad portfolio of chemicals to meet the needs of customers across diverse sectors such as Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, and more.
Written by Likesh Babu S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
